Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress Newmont Q1 2026 Earnings Strong EPS Beat Driven by Robust Gold Production and Cost Discipline CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance AVTX Q1 2026 Earnings Narrowed Loss Meets Expectations Amid Strategic Pivot PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues